PAMS
CLDX icon

Pictet Asset Management (Switzerland)’s Celldex Therapeutics CLDX Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio CLDX Stock Details CLDX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$60.9M Buy
2023
Q1 		$28.1M Buy